National Research Co. (NASDAQ:NRC) Shares Sold by Trexquant Investment LP

Trexquant Investment LP decreased its position in National Research Co. (NASDAQ:NRC - Free Report) by 47.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 29,954 shares of the company's stock after selling 27,348 shares during the period. Trexquant Investment LP owned about 0.13% of National Research worth $528,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. grew its position in National Research by 8.7% in the third quarter. JPMorgan Chase & Co. now owns 17,194 shares of the company's stock worth $393,000 after acquiring an additional 1,373 shares in the last quarter. Barclays PLC increased its position in shares of National Research by 65.6% during the third quarter. Barclays PLC now owns 51,331 shares of the company's stock valued at $1,175,000 after buying an additional 20,331 shares during the period. Geode Capital Management LLC lifted its stake in shares of National Research by 3.2% in the 3rd quarter. Geode Capital Management LLC now owns 420,733 shares of the company's stock valued at $9,619,000 after purchasing an additional 13,039 shares during the period. FMR LLC lifted its position in National Research by 397.3% during the third quarter. FMR LLC now owns 2,944 shares of the company's stock valued at $67,000 after buying an additional 2,352 shares during the period. Finally, Principal Financial Group Inc. boosted its position in shares of National Research by 10.7% in the 4th quarter. Principal Financial Group Inc. now owns 12,018 shares of the company's stock worth $212,000 after purchasing an additional 1,161 shares in the last quarter. 47.26% of the stock is owned by institutional investors.

National Research Stock Up 0.1 %

NRC stock traded up $0.01 during midday trading on Friday, hitting $10.54. The company's stock had a trading volume of 79,839 shares, compared to its average volume of 93,084. The company has a market cap of $241.85 million, a PE ratio of 10.04 and a beta of 0.41. The firm's 50-day moving average is $14.18 and its 200-day moving average is $16.96. National Research Co. has a 12 month low of $10.40 and a 12 month high of $35.81. The company has a current ratio of 0.47, a quick ratio of 0.47 and a debt-to-equity ratio of 1.30.

National Research (NASDAQ:NRC - Get Free Report) last posted its quarterly earnings data on Monday, January 27th. The company reported $0.28 earnings per share (EPS) for the quarter. National Research had a net margin of 17.32% and a return on equity of 66.52%.

National Research Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 4.55%. National Research's dividend payout ratio is presently 45.71%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.